Israeli blood test detects early breast cancer with 95% accuracy, assesses recurrence risk. Israeli researchers have developed a blood test that detects early-stage breast cancer with 95% accuracy and can also identify patients at increased risk of the disease returning, including some considered low-risk by conventional measures.
